Singapore markets open in 8 hours 29 minutes
Straits Times Index
3,367.90 +29.33 (+0.88%) S&P 500
5,478.34 +3.25 (+0.06%) Dow
39,115.23 -54.29 (-0.14%) Nasdaq
17,916.02 +36.72 (+0.21%) Bitcoin USD
61,827.78 -1,254.18 (-1.99%) CMC Crypto 200
1,307.48 -37.02 (-2.75%)
MAIA Biotechnology, Inc. (MAIA)
NYSE American - Nasdaq Real-time price. Currency in USD
Add to watchlist
As of 12:24PM EDT. Market open.
| Previous close | 3.4400 |
| Open | 3.4600 |
| Bid | 3.4600 x 2900 |
| Ask | 3.5000 x 800 |
| Day's range | 3.4000 - 3.6000 |
| 52-week range | 0.8200 - 5.9900 |
| Volume | |
| Avg. volume | 364,553 |
| Market cap | 74.246M |
| Beta (5Y monthly) | N/A |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -1.5700 |
| Earnings date | N/A |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 12.63 |
Business WireMAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
CHICAGO, June 07, 2024--MAIA Biotechnology's Telomere Targeting Functionality is Shown Viable by FDA’s Approval of a Telomerase Inhibitor Agent Therapy
Business WireMAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
CHICAGO, June 06, 2024--MAIA Biotechnology Announces Year-to-Date Achievements and Highlights Recent Clinical Progress for Novel Anticancer Agent
Business WireMAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
CHICAGO, June 04, 2024--MAIA Biotechnology Reveals New Clinical Data Showing THIO’s Strong Efficacy in Non-Small Cell Lung Cancer
© 2024 Yahoo. All rights reserved.